{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:29:47Z","timestamp":1793179787870,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL161365"],"award-info":[{"award-number":["R01HL161365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011926","name":"EAHAD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G072921N"],"award-info":[{"award-number":["G072921N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015438","name":"International Society on Thrombosis and Haemostasis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C14\/23\/121"],"award-info":[{"award-number":["C14\/23\/121"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008149","name":"Royal College of Pathologists of Australasia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011372","name":"RCPA Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011372","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtha.2025.04.026","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:27:34Z","timestamp":1746725254000},"page":"2371-2387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5539-0673","authenticated-orcid":false,"given":"Radha","family":"Ramanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Van Laer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Freson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.04.026_bib1","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.2023020118","article-title":"The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants","volume":"142","author":"Stefanucci","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"Downes","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2013.92","article-title":"Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee. ACMG clinical laboratory standards for next-generation sequencing","volume":"15","author":"Rehm","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jtha.2025.04.026_bib4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/jth.14479","article-title":"Subcommittee on Genomics in Thrombosis and Hemostasis. Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: communication from the SSC of the ISTH","volume":"17","author":"Megy","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jtha.2023.11.011","article-title":"Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework","volume":"22","author":"Ross","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib6","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/jth.14310","article-title":"Hemostatic abnormalities in patients with Ehlers\u2013Danlos syndrome","volume":"16","author":"Artoni","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pathol.2019.10.005","article-title":"An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet Group","volume":"52","author":"Rabbolini","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.jtha.2025.04.026_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0160-5402(80)90024-8","article-title":"The electronic aggregometer: a novel device for assessing platelet behavior in blood","volume":"3","author":"Cardinal","year":"1980","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.jtha.2025.04.026_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"Gresele","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib10","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib12","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1055\/a-2284-4285","article-title":"Thrombophilia testing: from genetic predisposition to discrimination","volume":"8","author":"Verstraete","year":"2024","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2025.04.026_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1160\/TH12-05-0361","article-title":"The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism","volume":"109","author":"Reitter\u2013Pfoertner","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib14","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.04.026_bib15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jtha.2024.12.006","article-title":"Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening","volume":"23","author":"Suchon","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib16","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200071","article-title":"Exome sequencing and multigene panel testing in 1,411 patients with adult-onset neurologic disorders","volume":"9","author":"Schuermans","year":"2023","journal-title":"Neurol Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib17","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/jth.14993","article-title":"Subcommittee on Genomics in Thrombosis, Hemostasis. Clinical management, ethics and informed consent related to multi-gene panel-based high throughput sequencing testing for platelet disorders: communication from the SSC of the ISTH","volume":"18","author":"Downes","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jtha.2025.04.026_bib19","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3390\/genes14081600","article-title":"MAGI-ACMG: algorithm for the classification of variants according to ACMG and ACGS recommendations","volume":"14","author":"Cristofoli","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.jtha.2025.04.026_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41431-021-00903-z","article-title":"Stepwise ABC system for classification of any type of genetic variant","volume":"30","author":"Houge","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib21","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen. ClinGen\u2014the Clinical Genome Resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.04.026_bib22","article-title":"The Clinical Genome Resource (ClinGen): advancing genomic knowledge through global curation","volume":"27","year":"2024","journal-title":"Genet Med"},{"key":"10.1016\/j.jtha.2025.04.026_bib23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/humu.24025","article-title":"The EAHAD blood coagulation factor VII variant database","volume":"41","author":"Giansily\u2013Blaizot","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2025.04.026_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/hae.13947","article-title":"The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: important resources for haemostasis clinicians and researchers","volume":"26","author":"McVey","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.04.026_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jth.12276","article-title":"An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B","volume":"11","author":"Rallapalli","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0031-1281031","article-title":"The international society on thrombosis and haematosis von Willebrand disease database: an update","volume":"37","author":"Hampshire","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib27","doi-asserted-by":"crossref","first-page":"E2382","DOI":"10.1002\/humu.22247","article-title":"The CDC Hemophilia A Mutation Project (CHAMP) mutation list: a new online resource","volume":"34","author":"Payne","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2025.04.026_bib28","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1111\/jth.15459","article-title":"GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis","volume":"19","author":"Megy","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib29","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2025.04.026_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jth.14777","article-title":"Gly197Arg mutation in protein C causes recurrent thrombosis in a heterozygous carrier","volume":"18","author":"Lu","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib31","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood.2024026454","article-title":"Functional assessment of genetic variants in thrombomodulin detected in patients with bleeding and thrombosis","volume":"145","author":"Van Laer","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2025.04.026_bib33","unstructured":"Schr\u00f6dinger, Inc. The PyMOL Molecular Graphics System, Version 1.8. 2015."},{"key":"10.1016\/j.jtha.2025.04.026_bib35","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ajhg.2016.04.003","article-title":"Consideration of cosegregation in the pathogenicity classification of genomic variants","volume":"98","author":"Jarvik","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","article-title":"ClinGen Sequence Variant Interpretation Working Group. ClinGen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification","volume":"111","author":"Biesecker","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1055\/s-0041-1739363","article-title":"F11 gene duplication causes elevated FXI plasma levels and is a risk for venous thrombosis","volume":"122","author":"Van Laer","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib118","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.04.026_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(72)90017-4","article-title":"Hereditary macrothrombocytopathia, nephritis and deafness","volume":"52","author":"Epstein","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.04.026_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/79063","article-title":"Mutations in MYH9 result in the May\u2013Hegglin anomaly, and Fechtner and Sebastian syndromes","volume":"26","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/324267","article-title":"Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May\u2013Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes","volume":"69","author":"Heath","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib41","first-page":"826","article-title":"Heavy chain myosin 9-related disease (MYH9-RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder","volume":"103","author":"Savoia","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib44","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib45","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2024024607","article-title":"Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition","volume":"144","author":"Zerella","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib46","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1182\/bloodadvances.2020004057","article-title":"Expanding the genetic spectrum of TUBB1-related thrombocytopenia","volume":"5","author":"Palma\u2013Barqueros","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.04.026_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1182\/blood-2008-06-162610","article-title":"Mutation of the \u03b21-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly","volume":"113","author":"Kunishima","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajhg.2013.01.015","article-title":"ACTN1 mutations cause congenital macrothrombocytopenia","volume":"92","author":"Kunishima","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib49","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2014-08-594531","article-title":"ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization","volume":"125","author":"Bottega","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib50","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2005.05658.x","article-title":"Genotype-phenotype correlation in MYH9-related thrombocytopenia","volume":"130","author":"Dong","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.04.026_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/humu.20661","article-title":"Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease","volume":"29","author":"Pecci","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2025.04.026_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejmg.2012.10.009","article-title":"MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype\/phenotype correlations","volume":"56","author":"De Rocco","year":"2013","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib53","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/jth.12368","article-title":"GFI1B mutation causes a bleeding disorder with abnormal platelet function","volume":"11","author":"Stevenson","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib54","doi-asserted-by":"crossref","unstructured":"Monteferrario D, Bolar NA, Marneth AE, Hebeda KM, Bergevoet SM, Veenstra H, Laros-van Gorkom BA, MacKenzie MA, Khandanpour C, Botezatu L, Fransen E, Van Camp G, Duijnhouwer AL, Salemink S, Willemsen B, Huls G, Preijers F, Van Heerde W, Jansen JH, Kempers MJ, et al. A dominant-negative GFI1B mutation in the Gray platelet syndrome. N Engl J Med 370(3):245\u2013253.","DOI":"10.1056\/NEJMoa1308130"},{"key":"10.1016\/j.jtha.2025.04.026_bib55","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/jth.13350","article-title":"Functional characterization of a novel GFI1B mutation causing congenital macrothrombocytopenia","volume":"14","author":"Kitamura","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib56","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/jth.13843","article-title":"Thrombocytopenia and CD34 expression is decoupled from \u03b1-granule deficiency with mutation of the first growth factor-independent 1B zinc finger","volume":"15","author":"Rabbolini","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib57","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood.2021014687","article-title":"Hematopoietic stem cell transplantation for Wiskott\u2013Aldrich syndrome: an EBMT Inborn Errors Working Party analysis","volume":"139","author":"Albert","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib58","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jaci.2018.06.042","article-title":"One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years","volume":"142","author":"Elfeky","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtha.2025.04.026_bib59","doi-asserted-by":"crossref","first-page":"101.e1","DOI":"10.1016\/j.jtct.2021.10.009","article-title":"Outcomes in hematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia","volume":"28","author":"Cancio","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtha.2025.04.026_bib60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.gene.2018.02.061","article-title":"Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2","volume":"656","author":"Kjeldsen","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.jtha.2025.04.026_bib61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3324\/haematol.2019.223966","article-title":"Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial","volume":"105","author":"Zaninetti","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.04.026_bib62","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jth.12196","article-title":"Inherited thrombocytopenias frequently diagnosed in adults","volume":"11","author":"Balduini","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib63","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3324\/haematol.2014.105924","article-title":"Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia","volume":"99","author":"Noris","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.04.026_bib64","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/09537104.2017.1356920","article-title":"Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia","volume":"29","author":"Rabbolini","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2025.04.026_bib65","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1073\/pnas.88.8.3160","article-title":"The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel","volume":"88","author":"Newman","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.04.026_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2021.102560","article-title":"Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients","volume":"89","author":"Rosenberg","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtha.2025.04.026_bib67","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.20130477","article-title":"Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding","volume":"211","author":"Canault","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2025.04.026_bib68","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2015-11-683102","article-title":"Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction","volume":"128","author":"Lozano","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib69","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-07-365635","article-title":"Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models","volume":"118","author":"Nurden","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034449","article-title":"Outside-in signalling generated by a constitutively activated integrin \u03b1IIb\u03b23 impairs proplatelet formation in human megakaryocytes","volume":"7","author":"Bury","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jtha.2025.04.026_bib71","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2013-06-506873","article-title":"Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects","volume":"122","author":"Stockley","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib72","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3324\/haematol.2016.146316","article-title":"Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects","volume":"101","author":"Johnson","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.04.026_bib73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.2017.171132","article-title":"Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders","volume":"103","author":"Bastida","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.04.026_bib74","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/rth2.12151","article-title":"A comprehensive targeted next-generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia","volume":"2","author":"Johnson","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"9 suppl","key":"10.1016\/j.jtha.2025.04.026_bib75","doi-asserted-by":"crossref","first-page":"94S","DOI":"10.1177\/1076029618790696","article-title":"Application of high-throughput sequencing in the diagnosis of inherited thrombocytopenia","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Appl Thromb"},{"key":"10.1016\/j.jtha.2025.04.026_bib76","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1055\/s-0038-1676813","volume":"2","author":"Andres","year":"2018","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2025.04.026_bib77","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjh.15886","article-title":"Outcome of an enhanced diagnostic pipeline for patients suspected of inherited thrombocytopenia","volume":"186","author":"Lein\u00f8e","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.04.026_bib78","first-page":"E26","article-title":"The limitation of genetic testing in diagnosing patients suspected for congenital platelet defects","volume":"95","author":"Blaauwgeers","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.04.026_bib79","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/hae.13948","article-title":"Genetic screening of children with suspected inherited bleeding disorders","volume":"26","author":"Andersson","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.04.026_bib80","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jtha.2022.12.007","article-title":"Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience","volume":"21","author":"Van Laer","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5\u2032 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"435\u20139","key":"10.1016\/j.jtha.2025.04.026_bib82","first-page":"S1","article-title":"Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome","volume":"44","author":"Albers","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102730","article-title":"Clinical utility of panel-based genetic sequencing for von Willebrand disease","volume":"9","author":"Ramanan","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib84","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.04.026_bib85","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1055\/s-0038-1649954","article-title":"Haemophilia A: mutation type determines risk of inhibitor formation","volume":"74","author":"Schwaab","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib86","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib87","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jtha.2023.01.001","article-title":"von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS","volume":"21","author":"Pagliari","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib88","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V99.10.3654","article-title":"Analysis of fibrinogen \u03b3-chain truncations shows the C-terminus, particularly \u03b3Ile387, is essential for assembly and secretion of this multichain protein","volume":"99","author":"Okumura","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib89","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1093\/hmg\/ddi360","article-title":"Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia","volume":"14","author":"Vu","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jtha.2025.04.026_bib90","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/jth.13021","article-title":"Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen \u03b3-module","volume":"13","author":"Asselta","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib91","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.35063","article-title":"Novel fibrinogen \u03b3375 Arg\u2192Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia","volume":"36","author":"Brennan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2025.04.026_bib92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9440(10)64530-0","article-title":"Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a \u03b3284 Gly\u2192Arg mutation","volume":"157","author":"Brennan","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtha.2025.04.026_bib93","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1478-3231.2010.02312.x","article-title":"Novel fibrinogen mutation \u03b3314Thr\u2192Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia","volume":"30","author":"Brennan","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jtha.2025.04.026_bib94","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1538-7836.2007.02713.x","article-title":"Fibrinogen angers with a new deletion (\u03b3 GVYYQ 346-350) causes hypofibrinogenemia with hepatic storage","volume":"5","author":"Dib","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib95","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.pathol.2017.03.007","article-title":"A novel fibrinogen gamma chain mutation (c.1096C>G; p.His340Asp), fibrinogen Ankara, causing hypofibrinogenaemia and hepatic storage","volume":"49","author":"Callea","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.jtha.2025.04.026_bib96","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.3390\/ijms21145139","article-title":"Structural characteristics in the \u03b3 chain variants associated with fibrinogen storage disease suggest the underlying pathogenic mechanism","volume":"21","author":"Burcu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.04.026_bib97","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/hae.15006","article-title":"A novel FGG missense variant associated with fibrinogen storage disease in a large family from Quebec","volume":"30","author":"Pelland\u2013Marcotte","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.04.026_bib98","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-2007-1000368","article-title":"Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes","volume":"33","author":"Othman","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib99","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/jth.12902","article-title":"Evaluation of von Willebrand factor phenotypes and genotypes in hemophilia A patients with and without identified F8 mutations","volume":"13","author":"Boylan","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0029-1222609","article-title":"Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia","volume":"35","author":"Franchini","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib101","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2141.2007.06693.x","article-title":"Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients","volume":"138","author":"Shetty","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.04.026_bib103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1160\/TH16-05-0375","article-title":"Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes","volume":"117","author":"Bastida","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.thromres.2019.06.015","article-title":"Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen","volume":"180","author":"Moret","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.04.026_bib105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2021.02.027","article-title":"The spectrum of FVIII gene variants detected by next generation sequencing in 236 Chinese non-inversion hemophilia A pedigrees","volume":"202","author":"Chen","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.04.026_bib107","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood.2023022457","article-title":"Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies","volume":"143","author":"Atiq","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib108","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2018-10-844936","article-title":"How I treat low von Willebrand factor levels","volume":"133","author":"Lavin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib109","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The Effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib110","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib111","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1182\/blood-2015-02-624551","article-title":"Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF","volume":"126","author":"Huffman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib102","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12908","article-title":"Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders","volume":"22","author":"Bastida","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.04.026_bib106","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bjh.14863","article-title":"Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the \u00d6resund Region, Scandinavia","volume":"179","author":"Lein\u00f8e","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.04.026_bib113","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/bloodadvances.2017005249","article-title":"Whole-exome sequencing in evaluation of patients with venous thromboembolism","volume":"1","author":"Lee","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.04.026_bib115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/diagnostics12051060","article-title":"Detection of Unknown and Rare Pathogenic Variants in Antithrombin, Protein C and Protein S Deficiency Using High-Throughput Targeted Sequencing","volume":"12","author":"Vrtel","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jtha.2025.04.026_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.12.041","article-title":"Multi-gene panel for thrombophilia testing in venous thromboembolism","author":"Verstraete","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.026_bib112","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s11239-024-02957-4","article-title":"Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry","volume":"57","author":"Cohen","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.04.026_bib116","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.2023023326","article-title":"Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank","volume":"143","author":"Ryu","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.026_bib117","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.jtha.2023.09.006","article-title":"Genomic science of risk prediction for venous thromboembolic disease: convenient clarification or compounding complexity","volume":"21","author":"Han","year":"2023","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:45:21Z","timestamp":1785552321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1538783625002776"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.04.026","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation and clinical utility of multigene panels for bleeding, platelet, and thrombotic disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}